PARK AVENUE SECURITIES LLC - SPDR SER TR ownership

SPDR SER TR's ticker is SJNK and the CUSIP is 78468R408. A total of 359 filers reported holding SPDR SER TR in Q4 2021. The put-call ratio across all filers is 6.00 and the average weighting 0.7%.

Quarter-by-quarter ownership
PARK AVENUE SECURITIES LLC ownership history of SPDR SER TR
ValueSharesWeighting
Q3 2023$2,076
+127.4%
84,859
+129.7%
0.03%
+128.6%
Q2 2023$913
-99.9%
36,949
+42.4%
0.01%
+27.3%
Q4 2022$629,000
-99.8%
25,949
+73.2%
0.01%
+57.1%
Q4 2021$407,000,000
+106724.1%
14,984
+7.9%
0.01%
-12.5%
Q3 2021$381,000
+27.9%
13,892
+28.7%
0.01%
+33.3%
Q2 2021$298,000
+1.0%
10,791
-0.1%
0.01%
-14.3%
Q1 2021$295,000
-2.0%
10,801
-3.4%
0.01%
-12.5%
Q4 2020$301,000
+9.5%
11,181
+5.1%
0.01%
-11.1%
Q3 2020$275,000
-34.1%
10,635
-39.9%
0.01%
-74.3%
Q1 2020$417,000
+19.1%
17,683
+36.1%
0.04%
+150.0%
Q4 2019$350,000
+11.5%
12,988
+11.8%
0.01%
-6.7%
Q3 2019$314,000
-19.3%
11,615
-17.6%
0.02%
-85.1%
Q4 2017$389,000
+1.3%
14,099
+2.3%
0.10%
-15.1%
Q3 2017$384,000
-17.4%
13,781
-17.5%
0.12%
+133.3%
Q2 2017$465,000
-5.3%
16,709
-5.3%
0.05%
-76.8%
Q1 2017$491,000
+13.1%
17,642
+13.0%
0.22%
+2.3%
Q4 2016$434,000
+65.6%
15,611
+63.9%
0.22%
+39.6%
Q3 2016$262,000
+13.4%
9,525
+10.6%
0.15%
+285.0%
Q2 2016$231,000
-99.9%
8,609
-36.6%
0.04%
-39.4%
Q1 2016$350,000,000
+54.9%
13,587
+54.2%
0.07%
+37.5%
Q4 2015$226,000,0008,8110.05%
Other shareholders
SPDR SER TR shareholders Q4 2021
NameSharesValueWeighting ↓
D'Orazio & Associates, Inc. 902,445$23,301,0009.79%
Astor Investment Management LLC 1,094,173$28,252,0004.83%
NOTTINGHAM ADVISORS, INC. 952,784$24,477,0004.55%
Tactical Allocation Group LLC 120,326$3,107,0004.52%
Efficient Market Advisors, LLC 978,552$25,266,0004.37%
Creative Planning 21,119,262$545,299,0004.25%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management 671,392$17,335,0004.19%
DeGreen Capital Management LLC 183,101$4,728,0004.09%
Dakota Wealth Management 197,206$5,092,0003.66%
Stratford Consulting, LLC 290,743$7,507,0003.52%
View complete list of SPDR SER TR shareholders